|Description||GSK1016790A is a novel and potent transient receptor potential vanilloid 4 (TRPV4) agonist. It has been used to demonstrate a role for TRPV4 in regulating urinary bladder activity and endothelial control of vascular tone. It elicited Ca2+ influx in mouse and human TRPV4 expressing HEK cells with EC50 values of 18 and 2.1 nM, respectively. It also evoked a dose-dependent activation of TRPV4 whole-cell currents at concentrations above 1 nM, which is 300 fold more potent than 4a-PDD. It was developed by GlaxoSmithKline.|
|B0084-382782||100 mg||$748||In stock|
|Solubility||DMSO ≥ 33 mg/mL|
|Application||GSK1016790A regulats urinary bladder activity and endothelial control of vascular tone.|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Density||1.426±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Tor|
|Current Developer||GSK1016790A was developed by GlaxoSmithKline.|
RN 9893 hydrochloride
RN 9893 is a potent and selective antagonist of the Transient Receptor Potential ion channel TRPV4 (IC50= 320, 420 and 660 nM for mouse, human and rat channels,...
OLDA is a vanilloid TRPV1 (VR1) receptor agonist with EC50 value of 36 nM at hVR1. OLDA is also a 5-lipoxygenase inhibitor with IC50 value of 7.5 nM.
AM 404 has been found to be an anandamide transport inhibitor and proved to exhibit effective in activating native and cloned vanilloid receptors.
A 784168 is a potent and selective TRPV1 antagonist (IC50 = 25 nM for inhibition of TRPV1 activation by 50 nM capsaicin) exhibiting no activity against a range ...
The hydrochloride salt form of AMTB, which has been found to be a TRPM8 channel blocker.
9-Phenanthrol, a cell permeable hydroxytricyclic derivative, functions as a selective inhibitor of TRPM4 (IC50 = 20 μM in HEK293 cells) and exhibits no effect o...
SAR7334, a TRPC6 inhibitor, could be valuable in studying sorts of diseases related to TRPC.
Arvanil is a vanilloid TRPV1 (VR1) and cannabinoid CB1 agonist with Ki values of 0.3 and 0.5 μM respectively. It increases lung tidal volume, diaphragm activity...